Story perspectives

Molecular Diagnostics Market Set to Nearly Double by 2030

2/22/2025

50 7

Summary

Diagnostics Market Surge

The global molecular diagnostics market is on a remarkable trajectory, soaring from USD 25.17 billion in 2023 to an anticipated USD 40.79 billion by 2030. This growth is fueled by the increasing prevalence of diseases and breakthroughs in personalized medicine. Key players like PCR and next-generation sequencing are leading the charge, while companion diagnostics, valued at USD 5.59 billion in 2022, is set to nearly triple, reaching USD 13.74 billion, highlighting the shift towards customized therapies.

Summary

Market Growth Challenges

The Breast Cancer Diagnostics Market is on a remarkable growth trajectory, soaring from USD 4.47 billion in 2023 to an anticipated USD 8.27 billion by 2032, fueled by innovative technologies and heightened awareness. However, the journey faces hurdles, with high costs and limited access posing significant challenges, especially in low-income areas.

1 of 2

Diagnostics Market Surge

The global molecular diagnostics market is on a remarkable trajectory, soaring from USD 25.17 billion in 2023 to an anticipated USD 40.79 billion by 2030. This growth is fueled by the increasing prevalence of diseases and breakthroughs in personalized medicine. Key players like PCR and next-generation sequencing are leading the charge, while companion diagnostics, valued at USD 5.59 billion in 2022, is set to nearly triple, reaching USD 13.74 billion, highlighting the shift towards customized therapies.

1 / 2